HUE032893T2 - Tejsavat tartalmazó hüvelykúp - Google Patents

Tejsavat tartalmazó hüvelykúp

Info

Publication number
HUE032893T2
HUE032893T2 HUE09757554A HUE09757554A HUE032893T2 HU E032893 T2 HUE032893 T2 HU E032893T2 HU E09757554 A HUE09757554 A HU E09757554A HU E09757554 A HUE09757554 A HU E09757554A HU E032893 T2 HUE032893 T2 HU E032893T2
Authority
HU
Hungary
Prior art keywords
lactic acid
vaginal suppository
suppository
vaginal
lactic
Prior art date
Application number
HUE09757554A
Other languages
English (en)
Inventor
Bjoern Andersch
Original Assignee
Rolf Kullgren Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolf Kullgren Ab filed Critical Rolf Kullgren Ab
Publication of HUE032893T2 publication Critical patent/HUE032893T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE09757554A 2008-06-04 2009-06-03 Tejsavat tartalmazó hüvelykúp HUE032893T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08157575A EP2130531A1 (en) 2008-06-04 2008-06-04 Vaginal suppository comprising lactic acid

Publications (1)

Publication Number Publication Date
HUE032893T2 true HUE032893T2 (hu) 2017-11-28

Family

ID=40040177

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE09757554A HUE032893T2 (hu) 2008-06-04 2009-06-03 Tejsavat tartalmazó hüvelykúp

Country Status (9)

Country Link
US (2) US8871244B2 (hu)
EP (2) EP2130531A1 (hu)
CN (1) CN102046148A (hu)
ES (1) ES2623382T3 (hu)
HR (1) HRP20170611T1 (hu)
HU (1) HUE032893T2 (hu)
PT (1) PT2306973T (hu)
SI (1) SI2306973T1 (hu)
WO (1) WO2009147173A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012092990A2 (de) 2011-01-05 2012-07-12 Udo Wenske Medizinprodukt zur verbesserung der konzeptionsfähigkeit eines säugetiers
EP2809301A1 (en) 2012-01-31 2014-12-10 Biosoma B.V. Method for administration of a probiotic
MX365905B (es) 2012-06-13 2019-06-18 Evofem Inc Composiciones y métodos para mejorar la eficacia de microbicidas anticonceptivos.
WO2014193279A1 (en) 2013-05-30 2014-12-04 Sca Hygiene Products Ab Composition comprising a buffered lactic acid
JP2017501227A (ja) 2013-12-19 2017-01-12 エヴォフェム，インク． アルギン酸をベースとする抗菌性化合物を使用して炎症と疾患を阻害するための組成物及び方法
CN103908469B (zh) * 2014-04-10 2016-03-23 南京明生医药技术有限公司 一种调节阴道微生态平衡和/或治疗萎缩性阴道炎的组合物及其应用
MX2018002533A (es) 2015-09-29 2018-06-27 Kimberly Clark Co Composicion sinergica para el mantenimiento de un equilibrio saludable de la microflora.
AU2017338748A1 (en) 2016-10-04 2019-05-02 Evofem Inc. Method of treatment and prevention of bacterial vaginosis
ES2811365T3 (es) * 2017-12-21 2021-03-11 S I I T S R L Servizio Int Imballaggi Termosaldanti Macrogols para aplicación a la mucosa, y sus usos terapéuticos
IT201900024132A1 (it) * 2019-12-16 2021-06-16 Idi Integratori Dietetici Italiani S R L Miscela e composizioni a base di oro e grafene, e loro uso.
US11850303B2 (en) 2020-10-27 2023-12-26 Uqora, Inc. Gel and a suppository and methods to provide the gel and suppository
GB202018068D0 (en) * 2020-11-17 2020-12-30 Ucl Business Ltd Pharmaceutical composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI68812C (fi) * 1978-08-21 1985-11-11 Dow Chemical Co Foerfarande foer framstaellning av terapeutiskt effektiva 1- och d,1-glausinlactatsalter
RO80931A2 (ro) * 1980-12-16 1983-02-01 Intreprinderea De Medicamente "Terapia",Ro Globule vaginale
SE8603338D0 (sv) 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan
DE19737348C2 (de) * 1997-08-27 2002-07-25 Dan-Gabriel Vulpescu Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung
US6740333B2 (en) * 2000-07-07 2004-05-25 Anestic Aps Suppository and composition comprising at least one polyethylene glycol
HU224320B1 (hu) * 2001-05-23 2005-07-28 József Szabó Lizozimot vagy lizozim-hidrokloridot tartalmazó hüvelyfertőtlenítő kúp
SE528337C2 (sv) * 2004-06-23 2006-10-24 Nestor Medical Ab Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet
US7786176B2 (en) * 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
AU2006209263A1 (en) * 2005-09-12 2007-03-29 Mcneil-Ppc, Inc. Anhydrous composition containing an acid-acid buffer system

Also Published As

Publication number Publication date
EP2306973B1 (en) 2017-01-25
SI2306973T1 (sl) 2017-06-30
EP2306973A1 (en) 2011-04-13
US8871244B2 (en) 2014-10-28
CN102046148A (zh) 2011-05-04
EP2130531A1 (en) 2009-12-09
ES2623382T3 (es) 2017-07-11
US20150080467A1 (en) 2015-03-19
PT2306973T (pt) 2017-04-26
WO2009147173A1 (en) 2009-12-10
US10016358B2 (en) 2018-07-10
HRP20170611T1 (hr) 2017-07-28
US20110098357A1 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
PT2306973T (pt) Supositório vaginal que compreende ácido láctico
GB0910302D0 (en) Nucleic acid amplification
PL2376020T3 (pl) Wkładka dopochwowa
PL2285329T3 (pl) Tampon
IL220368A0 (en) Anaerobic beactor
HK1225433A1 (zh) 改進的聯接裝置
EP2223697A4 (en) PREPARATION CONTAINING LACTIC ACID BACTERIUM
PL2417954T3 (pl) Tampon
EP2404585A4 (en) TAMPON
GB0918016D0 (en) Biosensor
EP2417953A4 (en) BUFFER
EP2439532A4 (en) BIOSENSOR
IL206524A0 (en) 4-dimethylminobutyric acid derivatives
EP2412349A4 (en) PLUG
EP2323606A4 (en) PATIENT TRANSFER
GB0803299D0 (en) Coupling
EP2451976A4 (en) NANO-BIOSENSORS WITH NUCLEIC ACIDS
ZA201204257B (en) Vaginal, speculum
GB0813581D0 (en) Transfer method
GB0817655D0 (en) Underwear
GB2462495B (en) Coupling
GB0917228D0 (en) An improved hitch
AU323407S (en) Tampon
AU323412S (en) Tampon
AU323409S (en) Tampon